AeroLeads people directory · profile
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof Email & Phone Number
Chief Executive Officer
at
Aivo Biosciences
LinkedIn matched
✓ Verified Jun 2026
3 data sources
Profile completeness 100%
Current company
Role
Chief Executive Officer
Location
Solana Beach, California, United States
Company size
Who is Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof is listed as Chief Executive Officer at Aivo Biosciences, a company with 1 employees, based in Solana Beach, California, United States. AeroLeads shows a matched LinkedIn profile for Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof.
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof previously worked as Founder, Biotech Consultant at Biotechgo Consulting and Adjunct Professor at University Of Helsinki. Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof holds Doctor Of Philosophy - Phd, Toxicology from University Of Helsinki.
Company email context
Email format at Aivo Biosciences
This section adds company-level context without repeating Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof's masked contact details.
Aivo Biosciences
Review company-level records connected to Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof before choosing the right outreach path.
Profile bio
About Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof
Science-driven and strategic R&D executive with 20+ years of broad biopharma industry experience in all phases of development, in programs involving small molecules, oligonucleotides, peptides, and various types of biologicals, for indications such as oncology, immunology / inflammation, CNS, pain, metabolism, and rare diseases. Contribution to clinical launch of more than 30 candidate drugs. Deep expertise in the areas of toxicology (incl. board certifications from the US and EU), drug discovery & development, translational medicine, project & portfolio management. Results-oriented operator with a demonstrated history of effectively building and operating biotech companies, taking them from academia into early clinical PoC, and eventually into exit (incl. Nasdaq). Track record in strategic planning, fund raising, budgeting, operations and business development. Strong communication, leadership and interpersonal skills. Built and transformed a San Diego -based academic startup into a clinical-stage biotech Cend Therapeutics, with the lead peptide product CEND-1 being tested in multiple clinical trials (operating the company into Phase 2 as the only FTE of the company 2017-2020). Cend was listed in Nasdaq as Lisata Therapeutics ($LSTA) in September 2022. Big pharma experience from AstraZeneca, toxicology project lead and portfolio management within Respiratory / Inflammation (Lund, Sweden) and CNS / Pain research areas (Montreal, Canada). Veterinary Medicine and PhD degrees from University of Helsinki, postdoctoral training at New York University Medical Center (New York, NY) and Max Planck Institute (Berlin, Germany). MBA (Medical Technology and Pharmaceuticals) from the University of New South Wales. Adjunct Professor of Toxicology at University of Helsinki since 2004. An author of >50 peer-reviewed scientific publications, patents, book chapters. Toxicology board certification toxicology from the US (DABT) and EU (ERT). Specialties: Drug discovery and development, oncology, solid tumors, cancer, CNS, gastrointestinal, IND, preclinical, clinical, toxicology, GLP, executive, pharmaceuticals, biologicals, peptides, RNA, pharmacology, management, Beijing, China, San Diego, Australia, India, Japan, CRO audit, GLP study monitoring, toxicology consultant.https://www.biotechgo.com/
Listed skills include Leadership, Quality Management, Laboratory, Global Alliance Management, and 46 others.
Current workplace
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof's current company
Company context helps verify the profile and gives searchers a useful next step.
Aivo Biosciences
13 roles · 23 years
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof work experience
A career timeline built from the work history available for this profile.
Founder, Biotech Consultant
CurrentIndependent technical and strategic support - especially preclinical/toxicology, regulatory and clinical - to virtual and emerging biotech firms globally, facilitating the development of innovative candidate drugs, always striving for maximum efficiency and cost-effectiveness. Deep expertise and familiarity with preclinical outsourcing in China. Consulting.
2015 - Present
~11 yrs 5 mos
Chief Executive Officer
CurrentPioneering New Therapeutics for Neuropsychiatric and Neurodegenerative Diseases.M1 muscarinic receptor agonist lead compound in late lead optimization stage - allosteric mechanism of action, subnanomolar potency.
Oct 2024 - Present
Adjunct Professor
Current
Sep 2004 - Present
Chief Operating Officer
Leadership for the operation of key business functions, including businessplanning, implementation of preclinical and clinical drug developmentprograms, manufacturing & supply chain, quality & regulatory affairs, BDand partnering.(temporary contract)
Jan 2023 - Jul 2023
Chief Operating Officer
Built and transformed a San Diego -based academic startup into a clinical-stage biotech Cend Therapeutics, with the lead peptide product CEND-1 being tested in multiple clinical trials (operating the company into Phase 2 as the only FTE of the company 2017-2020). Cend was listed in Nasdaq as Lisata Therapeutics ($LSTA) in September 2022.
Jan 2016 - Dec 2022
Chief Operating Officer
Zenopharm
Guided the New Orleans -based academic startup into a PoC-generating Phase 1.
Mar 2019 - Dec 2021
Vice President
- VP of Program Management (2014-2015):
- Translation of sponsors’ development strategy into study plans and schedules; coordination of activities. Ensuring effective translation/transition from non-clinical to clinical phase, preparation of reports.
- Oversee a section of the GLP Toxicology Department at Pharmaron Toxicology and Safety Pharmacology Laboratory.
2012 - 2015
~3 yrs
Research And Development Specialist
Food and supplement safety / toxicology. Leader of toxicology programs. Led outsourcing to generate safety data for regulatory dossiers.
2010 - 2012
~2 yrs
Principal Scientist
- Project toxicology leader / core team member for multiple phase I-enabling nonclinical studies and projects, author and contributor of 9 first-time-in-manregulatory packages, leader of discovery toxicology frontloading.
- Member of the Senior Scientific Management Committee managing theportfolio (Lund and Montreal).
- Global Due diligence / external research team member.
- Leader of industry-academia collaborations and funding schemes.
2006 - 2010
~4 yrs
Associate Principal Scientist
2003 - 2006
~3 yrs
Postdoctoral Researcher
Dec 2000 - 2003
Postdoctoral Researcher
Dec 2000 - 2003
7 education records
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof education
Doctor Of Philosophy - Phd, Toxicology
University Of Helsinki
Master Of Business Administration - Mba
Agsm @ Unsw Business School
Postdoc
Nyu Grossman School Of Medicine
Doctor Of Veterinary Medicine, Veterinary Medicine
University Of Helsinki
Postdoc
Max-Planck Institute For Infection Biology
Dabt, Toxicology
American Board Of Toxicology
Eurotox Registered Toxicologist, Toxicology
Eurotox
FAQ
Frequently asked questions about Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof
Quick answers generated from the profile data available on this page.
What company does Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof work for?
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof works for Aivo Biosciences.
What is Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof's role at Aivo Biosciences?
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof is listed as Chief Executive Officer at Aivo Biosciences.
Where is Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof based?
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof is based in Solana Beach, California, United States while working with Aivo Biosciences.
What companies has Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof worked for?
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof has worked for Aivo Biosciences, Biotechgo Consulting, University Of Helsinki, Ractigen Therapeutics, and Cend Therapeutics Inc.
How can I contact Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof?
You can use AeroLeads to view verified contact signals for Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof at Aivo Biosciences, including work email, phone, and LinkedIn data when available.
What schools did Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof attend?
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof holds Doctor Of Philosophy - Phd, Toxicology from University Of Helsinki.
What skills is Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof known for?
Harri Järveläinen, Dvm, Phd, Mba, Dabt, Ert, Prof is listed with skills including Leadership, Quality Management, Laboratory, Global Alliance Management, Clinical Trials, Cns Disorders, Translational Medicine, and Cro.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial